부광약품, 1분기 영업익 11억…전년비 62% 감소

Bukwang Pharm's significant drop in operating profit despite stable revenue highlights the increasing cost pressures and margin compression currently facing the traditional pharmaceutical sector. The shift to net profitability suggests a structural improvement in financial management or non-operating gains that may stabilize long-term valuation.